|
|
||||||||
U.S. Department of Agriculture, Beltsville, MD 20705
Abstract
In vitro incubation of swine adipose tissue slices in the presence or absence of insulin with a synthetic glucose tolerance factor (GTF) did not increase glucose utilization for oxidative metabolism or lipogenesis. GTF had no effect on glucose clearance rate or peak insulin response following an intravenous glucose challenge. Based on the glucose clearance rate and nominal stimulation of insulin release, swine have a very efficient glucose homeostatic mechanism. GTF did potentiate the hypoglycemic response following an intravenous insulin challenge. This latter observation indicates that GTF is biologically active in swine and is consistent with the hypothesis that the compound potentiates the insulin-insulin receptor interaction and subsequent biological response. Although GTF is biologically active in swine, the inclusion of trivalent chromium as an essential dietary trace element for swine would be speculative unless a true dietary deficiency of chromium can be demonstrated.
1 The authors gratefully acknowledge the advice of Dr. W. Mertz on the experimental design and Dr. R. Anderson for supplying the biologically active glucose tolerance factor.
2 Nonruminant Animal Nutrition Laboratory, Nutrition Institute.
3 Meat Science Laboratory, Agricultural Marketing Research Institute.
This article has been cited by other articles:
![]() |
J. C. Woodworth, M. D. Tokach, J. L. Nelssen, R. D. Goodband, S. S. Dritz, S. I. Koo, J. E. Minton, and K. Q. Owen Influence of dietary L-carnitine and chromium picolinate on blood hormones and metabolites of gestating sows fed one meal per day J Anim Sci, October 1, 2007; 85(10): 2524 - 2537. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. A. Van de Ligt, M. D. Lindemann, and G. L. Cromwell Assessment of chromium tripicolinate supplementation and dietary protein level on growth, carcass, and blood criteria in growing pigs J Anim Sci, September 1, 2002; 80(9): 2412 - 2419. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |